EUVIMEDEUVIMED entdecken
EditorialOpen Access

The inaugural HEMA report: a missed opportunity for comprehensive value assessment

Kimberly Westrich iD, Tyler D Wagner iD, Jonathan D Campbell iD

Journal of Comparative Effectiveness Research · 2026-05 · 15 (5)

DOI: 10.57264/cer-2026-0049 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Comparative Effectiveness Research, 2026-05. Verfasst von Kimberly Westrich und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Pharmaceutical Council, Washington, DC, 20006, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

economic evaluationhealth technology assessmentopportunity costpatient-centered outcomesvalue assessment

Autor:innen und Institutionen

  • National Pharmaceutical Council, Washington, DC, 20006, USA.

ORCID-Profile: Kimberly Westrich, Tyler D Wagner, Jonathan D Campbell

Zitieren

APA

Westrich, K., Wagner, T. D., & Campbell, J. D. (2026). The inaugural HEMA report: a missed opportunity for comprehensive value assessment. Journal of Comparative Effectiveness Research, 15(5). https://doi.org/10.57264/cer-2026-0049

Vancouver

Westrich K, Wagner TD, Campbell JD. The inaugural HEMA report: a missed opportunity for comprehensive value assessment. Journal of Comparative Effectiveness Research. 2026;15(5). doi:10.57264/cer-2026-0049

BibTeX
@article{Westrich2026,
  author = {Westrich, Kimberly and Wagner, Tyler D and Campbell, Jonathan D},
  title = {The inaugural HEMA report: a missed opportunity for comprehensive value assessment},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.57264/cer-2026-0049}
}
Kostenlos starten →